Hydroxychloroquine as Post Exposure Prophylaxis for SARS-CoV-2(HOPE Trial)

NCT04330144 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No Participants Enrolled

Conditions

Contact Person From COVID-19 Confirmed Patient

Interventions

DRUG: Hydroxychloroquine as post exposure prophylaxis
OTHER: Others(No intervention)

Sponsor

Gangnam Severance Hospital